Quantitative Estimation of D-Penicillamine in Pure and Pharmaceutical Samples Using Inhibitory Kinetic Spectrophotometric Method
Sulfur is the key element in a large number of drugs and bioactive molecules. Organo-sulfur compounds inhibit the catalytic efficiency of Hg2+ by forming a stable complex with it. The Hg2+ catalyzed exchange rate of cyanide with pyrazine from [Ru(CN)6]4- will be reduced by the addition of the sulfur-containing drug, D-penicillamine (D-PCN). This inhibitory property of D-PCN can be employed for its micro-level kinetic determination. Optimum reaction condition viz. Temperature = 45.0 ± 0.1 o C, I = 0.1 M (KCl), [Hg+2] = 1.5 × 10-4 M, [pyrazine] = 7.5 × 10-4 M, pH = 4.0 ± 0.02, and [Ru(CN)64-] = 5.25 × 10-5 M were utilized to investigate the kinetic measurements at 370 nm (λmax of [Ru(CN)5 Pz]3- complex). To acknowledge the inhibition induced by D-PCN on Hg2+ catalyzed substitution of cyanide with pyrazine from [Ru(CN)6]4-, a modified mechanistic scheme has been proposed. D-PCN can be quantitatively determined up to 1.0 × 10-6 M level by the proposed analytical method. The methodology can be economically and effectively employed for the quantitative determination of D-PCN in different samples. This methodology can also be convincingly adopted for the quick determination of D-PCN in the pharmaceutical samples with good accuracy and reproducibility. The addition of common excipients in pharmaceuticals even up to 1000 times with [D-PCN] does not interfere significantly in the estimation of D-PCN.